These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 17402345

  • 21. Fixed-duration multidrug therapy in multibacillary leprosy.
    Li HY, Hu LF, Wu PW, Luo JS, Liu XM.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V, Saha B, Hajra SK, Biswas SK, Saha K.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [Abstract] [Full Text] [Related]

  • 23. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
    Emmanuel M, Gupte MD.
    Indian J Lepr; 2005 Sep; 77(1):19-25. PubMed ID: 16173416
    [Abstract] [Full Text] [Related]

  • 24. Three years assessment of multidrug therapy in multibacillary leprosy cases.
    Ganapati R, Revankar CR, Pai RR.
    Indian J Lepr; 1987 Sep; 59(1):44-9. PubMed ID: 3611860
    [Abstract] [Full Text] [Related]

  • 25. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
    Katoch K, Katoch VM, Natrajan M, Sreevatsa, Gupta UD, Sharma VD, Shivanavar CT.
    Vaccine; 2004 Sep 09; 22(27-28):3649-57. PubMed ID: 15315844
    [Abstract] [Full Text] [Related]

  • 26. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
    Deshmukh AR, Dhurat RS, Jerajani HR.
    Indian J Lepr; 2003 Sep 09; 75(3):209-17. PubMed ID: 15267190
    [Abstract] [Full Text] [Related]

  • 27. A study on the impact of FD-MDT on 200 leprosy patients.
    Vara N, Marfatiya Y.
    Indian J Lepr; 2005 Sep 09; 77(3):217-27. PubMed ID: 16353520
    [Abstract] [Full Text] [Related]

  • 28. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
    Chen XS, Li WZ, Jiang C, Ye GY.
    Int J Lepr Other Mycobact Dis; 1999 Dec 09; 67(4):379-87. PubMed ID: 10700911
    [Abstract] [Full Text] [Related]

  • 29. WHO Expert Committee on Leprosy.
    World Health Organ Tech Rep Ser; 1998 Dec 09; 874():1-43. PubMed ID: 9627517
    [Abstract] [Full Text] [Related]

  • 30. Preliminary assessment of multidrug therapy in leprosy patients in Western Samoa.
    Paksoy N, Levi V.
    N Z Med J; 1989 Nov 08; 102(879):589-91. PubMed ID: 2812597
    [Abstract] [Full Text] [Related]

  • 31. International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.
    Kroger A, Pannikar V, Htoon MT, Jamesh A, Katoch K, Krishnamurthy P, Ramalingam K, Jianping S, Jadhav V, Gupte MD, Manickam P.
    Trop Med Int Health; 2008 May 08; 13(5):594-602. PubMed ID: 18346026
    [Abstract] [Full Text] [Related]

  • 32. Study of HLA-DR expression on skin lesions of leprosy before and during multiple drug therapy.
    Abdel Latif AM, Essa EA.
    Int J Lepr Other Mycobact Dis; 2002 Jun 08; 70(2):104-10. PubMed ID: 12211894
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD, Nasser S, Guerra P, Simon M, Birshner Rde C, Rodrigues LC.
    Lepr Rev; 2007 Sep 08; 78(3):216-22. PubMed ID: 18035772
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A comparative study between 12 and 24-dose therapeutic regimens for multibacillary leprosy patients.
    Sales AM, Sabroza PC, da Costa Nery JA, Duppre NC, Sarno EN.
    Int J Lepr Other Mycobact Dis; 2004 Sep 08; 72(3):320-3. PubMed ID: 15485290
    [Abstract] [Full Text] [Related]

  • 38. Multidrug therapy in leprosy.
    Manglani PR, Arif MA.
    J Indian Med Assoc; 2006 Dec 08; 104(12):686-8. PubMed ID: 17474286
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
    Fajardo TT, Villahermosa L, Pardillo FE, Abalos RM, Burgos J, Dela Cruz E, Gelber RH.
    Am J Trop Med Hyg; 2009 Aug 08; 81(2):330-4. PubMed ID: 19635893
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.